Cognition Therapeutics Ownership & Insider Activity

Cognition Therapeutics (CGTX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 3.8% of shares outstanding. Institutional investors hold 7.7%.

Shares Outstanding

95.094M

Shares Float

88.157M

Insider Shares Owned

3.621M

Insider % Owned

3.8%

Institutional Shares Held

7.328M

Institutional % Held

7.7%

Ownership Breakdown

Net Insider Activity by Month

Cognition Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Apr 16, 2026	John Brendan Doyle	CHIEF FINANCIAL OFFICER	BUY	10.000K	$1.13	$11K
Apr 16, 2026	Lisa Ricciardi	CEO & PRESIDENT	BUY	9.175K	$1.10	$10K
Apr 16, 2026	Anthony Caggiano	CHIEF MEDICAL OFFICER	BUY	10.000K	$1.11	$11K